Clinical and Epidemiological Features of Acute Lymphoblastic Leukemia Following a Previous Malignancy

References

• Boivin J K. Second cancers mid other late side effects of cancer treatment. A review. Cancer 1990; 65: 770–775
   Google Scholar
• Kyle R A. Second malignancies associated with chem-otherapeutic agents. Sem Oncol 1982; 9: 131–41
   PubMed Web of Science ®Google Scholar
• Coltman C. Treatment related leukemia. Acute leukemia, C D Bloomfield. Martinus Nijhoff, The Hague 1992; 61–108
   Google Scholar
• Pui C H, Rihriro R C, Hancock M L, Rivera G K, Evans W E, Raimondi S C, Head D R, Behm F G, Mahmoud M H, Sand-Land J T, et al. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. New Engl J Med 1991; 325: 1682–1687
   PubMed Web of Science ®Google Scholar
• Winick N J, McKenna R W, Shuster J J, Schncider N R, Borowitz M J, Bowman W P, Jacaruso D, Kamen B A, Buchanan G R. Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide. J Clin Oncol 1993; 11: 209–217
   PubMed Web of Science ®Google Scholar
• Maurizi Enrici R, Anselnio A P, Osti M F, Santoro M, Sbarbati Tombolini S. V, Mandelli F, D'Arcangelo E, Biagini C. Acute nonlymphocytic leukemia: onset after treatment for Hodg-kin's disease. Ann Hematol 1997; 74: 102–110
   Web of Science ®Google Scholar
• Kaldor J M, Day N E, Clarke E A, Van Leeuwen F E, Henry-Amar M, Fiorentino M V, Bell J, Pedersen D, Band P, Assouline D, et al. Leukemia following Hodgkin's disease. New Engl J Med 1990; 322: 7–13
   PubMed Web of Science ®Google Scholar
• Haas J F, Kittelmann B, Mehnert W H, Stancczek W, Mohner M., Kaldor J M, Day N E. Risk of leuknemia in ovarian tumor and breast cancer patients following treatment by cyclophos-phamide. Br J Cancer 1987; 55: 213–18
   PubMed Web of Science ®Google Scholar
• Coleman M P, Bell C MJ, Fraser P. Second primary malignaney after Hodgkin's disease, ovarian cancer and cancer of the testis: a population-based cohort study. Br J Cancer 1987; 56: 349–55
   PubMed Web of Science ®Google Scholar
• Brady L W. Conference on long term normal tissue effects of cancer treatment. Cancer Clin Trials 1981; 4(suppl)1–71
   Google Scholar
• International Agency for Research on cancer. Overall evaluations of careinogenicity: an updating of IARC monographs volumes 1 to 42. IARC monographs on the evaluation of careinogenic risks to humans. Unitecd Kingdom: International Agency for Research on Cancer. 1987; 40–46, supplement 7
   Google Scholar
• Wagoner J K. Lcukemia and other malignancies following radiation therapy for gynecological disorders. Radiation Careinogenesis: Epidemiology and biological significance, J D Boice, jr., J F Fraumeni, Jr. Raven press, New York 1984; 153–159
   Google Scholar
• Leone G, Mele L, Pulsoni A, Equitani F, Pagano L. The Incidence of secondary leukemias. Haematologica 1999; 84: 937–45
   PubMed Web of Science ®Google Scholar
• Leone G, Voxo M T, Morosetti R, Sica S, Pagano L. Therapy Related Leukemias: Susceptibility. Prevention and Treatment Leukemia & Lymphoma 2000, in press
   Google Scholar
• Hunger S P, Sklar J, Link M P. Acute lymphoblastic lcukemia occurring as a second malignant neoplasm in childhood: report of three cases and review of the literature. J Clin Oncol 1992; 10: 156–63
   PubMed Web of Science ®Google Scholar
• Imashuku S, Hibi S, Kosake K, Tabata Y, Naya M, Hohjo M, Todo S. Secondary lymphoid malignancy in two children with neuroblastoma. Med Pediatr Oncol 1996; 27: 54–6
   PubMedGoogle Scholar
• Emmi A, Ravindranath Y, Inoue S, Kaplan J, Lusher J M. Phenotypic changc ot acute monocytic leukemia to acute lymphoblastic leukemia on therapy. Am J Pediatr Hematol Oncol 1983; 5: 341–3
   PubMedGoogle Scholar
• Stess S, Mirro J, Melvin S, Pui C H, Murphy S B, Williams D. Lineage switch in acute leukemia. Blood 1984; 64: 701–6
   PubMed Web of Science ®Google Scholar
• Bernstein M L., Esseltine D W, Emond J, Vekemans M. Acute lymphohlestic leukemia at relapse in a child with acute myeloblastic leukemia. Am J Pediatr Hematol Oncol 1986; 8: 152–7
   Google Scholar
• Lampert Harbott F. J., Ludwig W D, Bartram C R, Ritter Gerein J. V, Neidhardt M, Mertens R, Graf N, Riehm H. Acute leukemia with chromosome translocation (4;11): 7 new patients and analysis of 71 cases. Blut 1987; 54: 325–35
   PubMedGoogle Scholar
• Shimizu H., Culbert S J, Cork A, Iacuone J J. A Image switch in acute monocytic Ieukemia. A Case report. Am J Pediatr Hematol Oncol 1989; 11: 162–6
   PubMedGoogle Scholar
• Hudxon M M, Raimondi S C, Behm F G, Pui C H. Childhod acute leukemia with 1(11;19) (q23;p1.3). Leukemia 1991; 5: 1064–8
   PubMed Web of Science ®Google Scholar
• Coad J E, Arthur D C, Gajl-Peczalska K J, Litz C E. Late-developing Philadelphia chromosomes in a case of T-cell acute lymphoblastic leukemia. Leukernia 1994; 8: 889–94
   Google Scholar
• Miller B A, Reid M M, Nell M, Lipton J M, Sallan S E, Nathan D G, Trantravahi R. T-cell acute lymphoblastic leukaemia with late developing Philadelphia chromosome. Br J Haematol 1984; 56: 130–46
   Web of Science ®Google Scholar
• Brizard A, Huret J L, Benz-Lemoine E, Guilhot F, Giraud C, Tanzer J. Two cases of t (4:11) acute lymphohlastic leukemia following All without t (4:11): second or secondary leukacmias?. Br J Haematol 1991; 79: 130–1
   PubMed Web of Science ®Google Scholar
• Tsuchiya H, Migita M, Yamamori S, Kaneko Y, Adachi N, Nokamura T, Nobukuni Y, el-Sonboty S S, Matsuda I. A late-appearing Philadelphia chromosome in acute lymphoblastic leukemia confirmed by expression of BCR-ABL mRNA. Leukemia 1995; 9: 1689–93
   PubMed Web of Science ®Google Scholar
• Suzuki T, Mugishima H, Yamada A, Nagata T, Shichino H, Chin M, Imashuku S, Harada K. Development of acute lymphoblastic leukemia following hemophagocytic lymphohistiocytosis: is it secondary leukemia?. Int J Hematol 1999; 70: 58–9
   PubMed Web of Science ®Google Scholar
• van der Velden J W, van Putten W L, Guinee V F, Pfeiffer R, van Leeuwen F E, van der Linden E A, Vardomskaya Lane I., Durand W, Lagarde C M, et al. Subsequent development of acute nonlymphocytic leukemia in patients treated for Hodgkin's disease. Int J Cancer 1988; 42: 252–55
   PubMed Web of Science ®Google Scholar
• Witherspoon R P, Fisher L D, Schoch G, Martin P, Sullivan K M, Sanders J, Deeg H J, Doney K, Thomas D, Storb R, Thomas D. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. New Engl J Med 1989; 321: 784–9
   PubMed Web of Science ®Google Scholar
• Kaldor J M, Day N E, Pettersson F, Clarke E A, Pederben D, Mehnert W, Bell J, Host H, Prior P, Karjalainen S, et al. Leukemia following chemotherapy for ovarian cancer. New Engl J Med 1990; 322: 1–6
   PubMed Web of Science ®Google Scholar
• Curtis R E, Boice J D, Jr, Moloney W C, Ries L G, Flannery J T. Leukemia following chemotherapy for breast cancer. Cancer Res 1990; 50: 2741–6
   PubMed Web of Science ®Google Scholar
• Bokemeyer C, Schmoll H J. Secondary neoplasms following treatment of malignant gem cell tumors. J Clin Oncol 1993; 11: 1703–9
   PubMed Web of Science ®Google Scholar
• Tallman M S, Gray R, Bennett J M, Variakojis D, Robert N, Wood W C, Rowe J M, Wiernik P H. Leukemogenic potential of adjuvant chemotherapy for early-stage breast cancer: the Eastern Cooperative Oncology Group experience. J Clin Oncol 1995; 13: 1557–63
   PubMed Web of Science ®Google Scholar
• Travis L B, Curtis R E, Storm H, Hall P, Holowaty E, Van Leeuwen F E, Kohler B A, Pukkala E, Lynch C F, Andersson M, Bergfeldt K, Clarke E A, Wiklund T, Stoter G, Gospo-Darowicz M, Sturgeon J, Fraumeni J F, Jr, Boice J D, Jr. Risk of second malignant neoplasms among long-tem survivors of testicular cancer. J Natl Cancer lnst 1997; 89: 1429–39
   PubMed Web of Science ®Google Scholar
• Laughlin M J, McGaughey D S, Crews J R, Chao N J, Rizzieri D, Ross M, Cockerman J, Cirrincione C, Berry D, Mills L, Defusco P, Le Grand S, Peters W, Vredenburgh J J. Secondary myelndysplasia and acute leukemia in breast cancer patients after autologous bone marrow transplant. J Clin Oncol 1998; 6: 1008–12
   Google Scholar
• Levine M N, Bramwell V H, Pritchard Kl, Norris B D, Shepherd L E, Abu-Zahra H, Findlay B, Warr D, Bowman D, Myles J, Arnold A, Vandenberg T, MacKenzie R, Robert J, Ottaway J, Burnell M, Williams C K, Tu D. Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 1998; 16: 2651–8
   PubMed Web of Science ®Google Scholar
• Cutuli B, Janvier M, de la Rochefordiere A, Julien J P, Isam-Bert N, Alzieu C, Kerbrat P, de Lafontan B, van Lemmens L, Cure H, Ganem G, Baume D, Le Mevel A, Lorthoraly A, de Gislain C, Marchal C, Chevelle C, Lauche H, Serin D. Leukemia and pre-leukemic conditions occurring after treatment of breast cancer. F'resse Med 2000; 29: 135–8
   Google Scholar
• Sonneveld P, Hagemeijer A, Abels J. Acute lymphoblastic leukaemia occurring 6 years after treatment of Hodgkin's disease. Br J Haematol 1988; 68: 261–2
   PubMed Web of Science ®Google Scholar
• Copelan E, Kapoor N, Murcek M, Theil K, Tutschka P. Marrow transplantation following busulphan and cyclophosphamide as treatment for translocation (4; 11) acute leukemia. Br J Haematol 1988; 70: 127–8
   PubMed Web of Science ®Google Scholar
• Orazi A, Sozzi G, Cattoretti G, De Braud F, Delia D. Acute leukaemia with t (4; 11) chromosome translocation following treatment for Hodgkin's disease: a case study. Haematologica 1988; 73: 279–83
   PubMed Web of Science ®Google Scholar
• Archimbaud E, Charrin C, Guyotat D, Magaud J P, Gentil-Homme O. Acute leukaemia with t (4;11) in patients previously exposed to carcinoeens. Br J Haematol 1988; 69: 467–70
   PubMed Web of Science ®Google Scholar
• Guinea J M, Marimon M, Menchaca M C, Perez Clausell C. Acute lymphoblastic leukemia as a second neoplasia in Hodgkin's disease. Sangre 1992; 37: 303
   PubMedGoogle Scholar
• Kapelushnik J, Dube I, Wilson P, Greenberg M. Acute lymphoblastic leukemia with t (4:11) translocation after osteogenic sarcoma. Cancer 1991; 67: 2887–89
   PubMed Web of Science ®Google Scholar
• Soutar R L, Dawson A A. Breast carcinoma and secondary acute lymphoblastic leukaemia responding to leukaemic chemotherapy. Clin Lab Haematol 1990; 12: 355–6
   PubMedGoogle Scholar
• Bokemeyer C, Schmoll H J. Secondary neoplasms following treatment of malignant germ cell tumors. J Clin Oncol 1993; 11: 1703–9
   PubMed Web of Science ®Google Scholar
• Lennard A, Jackson G H, Carey P J, Bown N, Middleton P, Proctor S J. Secondary acute lymphoblastic leukaemia with 4: 11 translocation following treatment for Hodgkin's diasease: case report and review of the literature. Leukemia 1991; 5: 624–7
   PubMed Web of Science ®Google Scholar
• Kaplinsky C, Frisch A, Cohen I J, Goshen Y, Jaber Yaniv L. I, Stark B, Tamary H, Zaizov R. T-cell acute lymphoblastic leukemia following therapy of rhabdomyosarcoma. Med Pediatr Oncol 1992; 20: 229–31
   PubMedGoogle Scholar
• Auxenfants E, Morel P, Lai J L, Sartiaux C, Detourmignies L, Bauters F, Fenaux P. Secondary acute lymphoblastic leukemia with t(4; 11): report of two cases and review of the literature. Ann Hematol 1992; 65: 143–6
   PubMed Web of Science ®Google Scholar
• Zhang Y, Poetsch M, Weber-Matthiesen K, Rohde K, Winke-Mann M, Haferlach T, Gassmann W, Ludwig W D, Grote W, Loffler H, Schlegelberger B. Secondary acute leukaemias with 11q23 rearrangement: clinical, cytogenetic, FISH and FICTION studies. Br J Haematol 1996; 92: 673–80
   PubMed Web of Science ®Google Scholar
• Geetha N, Sreedevi Amma N, Kusumakumary P, Lali V S, Nair M K. Acute lymphoblastic leukemia occurring as a second malignancy: report of a case and review of literature. Pediatr Hematol Oncol 1999; 16: 267–70
   PubMed Web of Science ®Google Scholar
• Al-Homaidhi A M, Patterson B, Rubin S, Liptnn J H. Acute lymphoblastic leukemia with multiple cytogenetic abnormalities secondary to treatment of Ewing's sarcoma. Leuk Res 1999; 23: 593–6
   PubMed Web of Science ®Google Scholar
• Liso V, Specchia G, Pannunzio A, Mestice A, Palumbo G, Biondi A. T-cell acute lymphoblastic leukemia occurring in a patient with acute promyelocytic leukemia. Haematologica 1998; 83: 471–3
   PubMed Web of Science ®Google Scholar
• Marcus R E, Matutes E, Drysdale H, Catovsky D. Phenotypic conversion of TdT+ adult AML to CALLA+ ALL. Scand J Haematol 1985; 35: 343–7
   PubMedGoogle Scholar
• Lounici A, Cony-Makhoul P, Lacombe F, et al. Acute lymphoblastic leukemia at relapse in an adult with acute myeloid leukemia. Blood 1996; 88(suppl 1)33–91
   Google Scholar
• Dawson L, Slater R, Hagemeijer A, Langerak A W, Willemze R, Kluin-Nelemans J C. Secondary T-acute lymphoblastic leukaemia mimicking blast crisis in chronic myeloid leukaemia. Br J Haematol 1999; 106: 104–6
   PubMed Web of Science ®Google Scholar
• Sessarego M, Defferrari R, Dejana A, Salvidio E. Late-appearing Philadelphia chromosome in acute lymphoblastic leukemia. Cancer Genet Cytogenet 1990; 48: 35–8
   PubMed Web of Science ®Google Scholar
• Bayer R, Kolitz J E, Allen S L, Schulman P, Brody J, Koduru P. Late appearance of the Philadelphia (Phl) chromosome in acute lymphocytic leukemia. Blood 1996; 88: 3332
   Web of Science ®Google Scholar
• Pedersen-Bjergaard J, Brondum-Nielsen K, Karle H, Johansson B. Chemotherapy-related - late occurring - Philadelphia chromosome in AML, ALL and CML. Similar events related to treatment with DNA topoisomerase II inhibitors? Leukemia 1997; 11: 1571–4
   Google Scholar
• Escudier S M, Albitar M, Robertson L E, Andreeff M, Pierce S, Kantarjian H M. Acute lymphoblastic leukemia following preleukemic syndromes in adulis. Leukemia 1906; 10: 173–7
   Google Scholar
• Hernandez J M, Sanchez Gonzales I., Orfao M. A, Gonzales-Sarmiento R, San Miguel J F. Acute lymphoid leukemias following either a previous chronic myclogenous leukemia or myelodysplastic syndrome: phenotypic and genomic difference. Am J Hematol 1903; 43: 256–58
   Web of Science ®Google Scholar
• Pagano L, Pulsoni A, Tosti M E, Mele A, Mele L, Corvatta L, Miraglia E, Almici C, Manna A, Del Poeta G, Lanza F, Masini L, Recchia A, Equitani F, Leone G, Mandelli F., for the GIMEMA (Grupyo Italiano Malattie Ematologiche dell'Adulto). Acute leukemia following a previous malignancy. Have both acute lymphoid leukemia and acute mye-loid leukemia common risk factors?. Hematol J. 2000, in press
   PubMedGoogle Scholar
• Pagano L, Pulsoni A, Tosti M E, Annino L, Mele A, Camera A, Martino B, Guglielini C, Cerri R, Di Bona E, Invernizzi R, Castagnola C, Bassan R, Mele L, Todeschini G, Leone G, Mandelli F. Acute lymphoblastic leukaemia occurring as second malignancy: report of the GIMEMA archive of adult acute leukaemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. Br J Hacmatol 1999; 106: 1037–40
   PubMed Web of Science ®Google Scholar
• Grigg A P. Approaches to the treatment of Phl chromosome positive acute lymphoblastic leukemia. Bone Marrow Transplant 1943; 12: 431–5
   Google Scholar
• Tefft M, Vawter G F, Mitus A. Second primary neoplasms in children. Am J Roentgenol 1968; 103: 800–22
   Web of Science ®Google Scholar
• Cimino G, Rapanotti M C, Biondi A, et al. Infant acute leukemia show the same biased distribution of ALL 1 gene breaks as topoisomerasc II related secondary acute leukemias. Cancer Research 1997; 57: 2879–83
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Hayashi Y, Ozawa K, Asano S. HRX gene rearrangement in secondary acute lymphoblaslic leukaemia. Leuk and Lymphoma 1995; 17: 391–9
   PubMed Web of Science ®Google Scholar
• Grunwald H W, Rosner F. Acute inycloid leukemia following treatment of Hodgkin's tliseiise. Cancer 1982; 50: 676–83
   PubMed Web of Science ®Google Scholar
• Martin P J, Najfeld V, Hansen J A, Penfold G K, Jacobson R J, Fialkow P J. Involvement of the B-lymphoid system in chronic myelogenous leukaemia. Nature 1980; 287: 40–50
   Web of Science ®Google Scholar
• Fialkow P J, Jacobson R J, Papayannopoulou T. Chronic mye-locytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte. platelet and monocyte/macrophage. Am J Med 1977; 63: 125–30
   PubMed Web of Science ®Google Scholar
• Green D M, Zevon M A, Reese P A, Lowrie G S, Gaeta J F, Pearce J I, Michalek A M, Stephens E A. Second malignant tumors following treatment during childhood and dolescence for cancer. Med Pediatr Oncol 1994; 27: 1–10
   Google Scholar
• Pottern L M, Linet M, Blair A, Dick F, Burmeister L F, Gibson R, Schuman L M, Fraumeni J F, Jr. Familial cancers associated with subtypes of leukemia and non-Hodgkin's lymphoma. Lcuk Res 1991; 15: 305–14
   Google Scholar